Form 4: NHI Director Awarded Restricted Stock Grant

National Health Investors Director Robert A. McCabe Jr. received a grant of 1,268 restricted shares of common stock.

Summary

• Director Robert A. McCabe Jr. of National Health Investors Inc. (NHI) was granted 1,268 shares of common stock.
• The transaction occurred on March 3, 2026.
• These shares are restricted stock, awarded at a price of $0.
• The restricted stock vests in full on March 3, 2027, contingent on Mr. McCabe's continued service as a director.
• Following this transaction, Mr. McCabe directly beneficially owns 43,268.96 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting continued director commitment and a standard compensation practice, which generally aligns director interests with long-term shareholder value.

Positives

• Increased direct ownership for Director Robert A. McCabe Jr. by 1,268 shares, aligning his interests further with shareholders.
• The grant of restricted stock at a $0 price indicates a compensation component, often used to incentivize long-term commitment.

Negatives

• No direct negatives are apparent from this Form 4 filing, as it reports a standard compensation event.

Risks

• The restricted stock grant is subject to a vesting condition, meaning the director must continue service until March 3, 2027, to fully realize the benefit.

Future Outlook

The vesting of the restricted stock on March 3, 2027, indicates an expectation of continued service from Director Robert A. McCabe Jr. through that date.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common form of executive and director compensation in the real estate investment trust (REIT) sector, particularly for healthcare REITs like National Health Investors, aligning long-term incentives with company performance and shareholder value.

Related Party Transactions

• The grant of restricted stock to Director Robert A. McCabe Jr. is a related party transaction, representing compensation from the company to an insider.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders by increasing his equity stake, incentivizing long-term performance.
• Director (Robert A. McCabe Jr.): Receives additional equity compensation, contingent on continued service.

Next Steps

• Director Robert A. McCabe Jr. is expected to continue his service as a director until at least March 3, 2027, for the restricted stock to fully vest.

Key Dates

Recommendation

This Form 4 filing reports a routine restricted stock grant to a director, which is a standard compensation practice and does not provide new fundamental information to warrant a change in investment recommendation. It reinforces director alignment but doesn't signal a significant shift in company prospects.

Keywords

National Health Investors, NHI, Form 4, Insider Transaction, Restricted Stock, Director Compensation, Equity Grant, Robert A. McCabe Jr.